NASDAQ:OPCH - Option Care Health Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $23.75
  • Forecasted Upside: 11.82 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
▲ +0.01 (0.05%)

This chart shows the closing price for OPCH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Option Care Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OPCH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OPCH

Analyst Price Target is $23.75
▲ +11.82% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Option Care Health in the last 3 months. The average price target is $23.75, with a high forecast of $25.00 and a low forecast of $21.00. The average price target represents a 11.82% upside from the last price of $21.24.

This chart shows the closing price for OPCH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Option Care Health. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/19/2021The Goldman Sachs GroupUpgradeNeutral ➝ Buy$20.00 ➝ $25.00Low
3/12/2021Barrington ResearchUpgradeOutperform$19.00 ➝ $24.00High
3/12/2021Canaccord GenuityBoost Price TargetBuy$20.00 ➝ $24.00High
3/12/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$22.00 ➝ $23.50High
1/25/2021TruistBoost Price Target$21.00 ➝ $25.00Low
1/22/2021Deutsche Bank AktiengesellschaftInitiated CoverageBuy$22.00Medium
1/11/2021JPMorgan Chase & Co.Initiated CoverageOverweight$21.00Low
12/15/2020The Goldman Sachs GroupInitiated CoverageNeutral$18.00Low
11/4/2020Canaccord GenuityBoost Price TargetBuy$18.00 ➝ $20.00Low
8/5/2020Barrington ResearchBoost Price TargetOutperform$17.00 ➝ $19.00High
7/21/2020SunTrust BanksBoost Price TargetBuy$18.00 ➝ $21.00High
6/24/2020Bank of AmericaInitiated CoverageBuy$18.00High
3/19/2020Canaccord GenuityReiterated RatingBuy$20.00High
3/9/2020Canaccord GenuityReiterated RatingBuy$20.00Medium
2/19/2020Lake Street CapitalBoost Price TargetBuy$18.00 ➝ $23.00High
1/6/2020William BlairInitiated CoverageOutperformLow
9/20/2019SunTrust BanksBoost Price TargetBuy$3.25 ➝ $4.25Low
8/8/2019Canaccord GenuityBoost Price TargetBuy$3.50 ➝ $4.00High
5/3/2019Barrington ResearchReiterated RatingBuy$4.00Low
3/18/2019Canaccord GenuityLower Price TargetBuy ➝ Buy$5.00 ➝ $3.50High
3/18/2019StephensDowngradeOverweight ➝ Equal Weight$2.51High
12/12/2018Canaccord GenuityInitiated CoverageBuy$5.00High
12/7/2018Lake Street CapitalBoost Price TargetBuy$4.50 ➝ $10.00Medium
10/5/2018Barrington ResearchReiterated RatingBuy$4.00Low
8/8/2018Barrington ResearchReiterated RatingBuy$4.00Medium
3/8/2018SunTrust BanksReiterated RatingBuy$3.25Medium
3/8/2018Craig HallumReiterated RatingBuy$3.50Medium
12/21/2017SunTrust BanksSet Price TargetBuy$4.00High
11/3/2017SunTrust BanksReiterated RatingBuy$3.00N/A
8/10/2017SunTrust BanksUpgradeHold ➝ Buy$3.25 ➝ $3.75High
8/10/2017Jefferies Financial GroupReiterated RatingBuy$3.00 ➝ $4.00High
6/26/2017Barrington ResearchBoost Price TargetOutperform$3.50High
3/6/2017Barrington ResearchBoost Price TargetOutperform ➝ Outperform$1.50 ➝ $2.25N/A
3/6/2017Jefferies Financial GroupBoost Price TargetBuy$2.50 ➝ $3.00N/A
1/3/2017Lake Street CapitalInitiated CoverageBuy$4.50N/A
11/8/2016Jefferies Financial GroupInitiated CoverageBuy$2.50N/A
(Data available from 7/23/2016 forward)
Option Care Health logo
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Read More

Today's Range

Now: $21.24
Low: $21.16
High: $21.57

50 Day Range

MA: $20.36
Low: $17.25
High: $22.45

52 Week Range

Now: $21.24
Low: $10.52
High: $22.69


416,130 shs

Average Volume

1,147,417 shs

Market Capitalization

$3.82 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Option Care Health?

The following Wall Street research analysts have issued research reports on Option Care Health in the last year: Barrington Research, Canaccord Genuity, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., The Goldman Sachs Group, Inc., Truist, and Zacks Investment Research.
View the latest analyst ratings for OPCH.

What is the current price target for Option Care Health?

6 Wall Street analysts have set twelve-month price targets for Option Care Health in the last year. Their average twelve-month price target is $23.75, suggesting a possible upside of 12.0%. The Goldman Sachs Group, Inc. has the highest price target set, predicting OPCH will reach $25.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $21.00 for Option Care Health in the next year.
View the latest price targets for OPCH.

What is the current consensus analyst rating for Option Care Health?

Option Care Health currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OPCH will outperform the market and that investors should add to their positions of Option Care Health.
View the latest ratings for OPCH.

What other companies compete with Option Care Health?

Other companies that are similar to Option Care Health include Amedisys, Chemed, LHC Group, Signify Health, AdaptHealth, Aveanna Healthcare, Addus HomeCare, Apria, Cancer Treatment and New York Health Care.

How do I contact Option Care Health's investor relations team?

Option Care Health's physical mailing address is 3000 Lakeside Dr. Suite 300N, Bannockburn IL, 60015. The company's listed phone number is 312-940-2443 and its investor relations email address is [email protected] The official website for Option Care Health is